A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux(R)) in Healthy Chinese Male Subjects

发表于 2026-7-6 14:56:29

期刊：Advances in Therapy

文献作者：Jia Xu; Junyou Ge; Yaling Li; Shulin Liu; Sicong Li; Jing Si; Juncheng Liu; Xiaoxue Zhu; Yanhua Ding

出版日期：2025-6-

DOI号：10.1007/s12325-025-03193-9

下载链接：https://link.springer.com/conten ... 325-025-03193-9.pdf

文献链接：https://doi.org/10.1007/s12325-025-03193-9

当前文献来源于 Springer Science and Business Media LLC。

备注信息：

发表于 2026-7-6 14:56:30

: 当前求助已完成，请重新发起求助。
已完结状态的附件将会在24小时内删除。

[Springer] A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux(R)) in Healthy Chinese Male Subjects

已采纳

同分类求助

最新回复

站点公告

今日热心研友

（热心研友QQ群）

[Springer] A Phase I Study Comparing the Pharmacokinetics, Safety, and Immunogenicity of A140 Injection and Cetuximab (Erbitux(R)) in Healthy Chinese Male Subjects 一键复制

已采纳